Clinical Trial Update: Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating serial MR imaging and MR spectroscopy to characterize lower-grade gliomas (WHO grade II/III), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower-grade Glioma

Snippet

Sponsor: Susan Chang | Conditions: Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma | Phase 1 | Status: RECRUITING